Skip to main content

Table 4 Adverse events in FMT and GCs groups

From: Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis

 

FMT group (n = 62)

GCs group (n = 60)

p value

Patients with adverse events, n (%)

14 (22.6)

36 (60.0)

 

Total events (n)

17

68

p < 0.001

Colectomy

0 (0)

2 (33.3)

 

Leukopenia, n (%)

0 (0)

3 (5)

 

Abnormal liver function, n (%)

0 (0)

2 (3.3)

 

Electrolyte disorder, n (%)

0 (0)

10 (16.7)

 

Cytomegalovirus infection, n (%)

0 (0)

2 (3.3)

 

Hyperglycemia, n (%)

0 (0)

6 (10)

 

Hypertension, n (%)

0 (0)

4 (6.7)

 

Gastrointestinal discomfort, n (%)

12 (19.4)

18 (30.0)

 

Fever, n (%)

5 (8.1)

0 (0)

 

Insomnia, n (%)

0 (0)

21 (35)

 
  1. FMT fecal microbiota transplantation, GCs glucocorticoids